Your browser doesn't support javascript.
loading
Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors.
Schmidt, Julien; Chiffelle, Johanna; Perez, Marta A S; Magnin, Morgane; Bobisse, Sara; Arnaud, Marion; Genolet, Raphael; Cesbron, Julien; Barras, David; Navarro Rodrigo, Blanca; Benedetti, Fabrizio; Michel, Alexandra; Queiroz, Lise; Baumgaertner, Petra; Guillaume, Philippe; Hebeisen, Michael; Michielin, Olivier; Nguyen-Ngoc, Tu; Huber, Florian; Irving, Melita; Tissot-Renaud, Stéphanie; Stevenson, Brian J; Rusakiewicz, Sylvie; Dangaj Laniti, Denarda; Bassani-Sternberg, Michal; Rufer, Nathalie; Gfeller, David; Kandalaft, Lana E; Speiser, Daniel E; Zoete, Vincent; Coukos, George; Harari, Alexandre.
Afiliação
  • Schmidt J; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.
  • Chiffelle J; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.
  • Perez MAS; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
  • Magnin M; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.
  • Bobisse S; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.
  • Arnaud M; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.
  • Genolet R; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.
  • Cesbron J; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.
  • Barras D; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.
  • Navarro Rodrigo B; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.
  • Benedetti F; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.
  • Michel A; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.
  • Queiroz L; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.
  • Baumgaertner P; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.
  • Guillaume P; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.
  • Hebeisen M; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.
  • Michielin O; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.
  • Nguyen-Ngoc T; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.
  • Huber F; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.
  • Irving M; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.
  • Tissot-Renaud S; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.
  • Stevenson BJ; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.
  • Rusakiewicz S; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.
  • Dangaj Laniti D; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.
  • Bassani-Sternberg M; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.
  • Rufer N; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.
  • Gfeller D; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.
  • Kandalaft LE; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.
  • Speiser DE; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
  • Zoete V; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.
  • Coukos G; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.
  • Harari A; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Nat Commun ; 14(1): 3188, 2023 06 06.
Article em En | MEDLINE | ID: mdl-37280206
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pele Base de dados: MEDLINE Assunto principal: Melanoma Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pele Base de dados: MEDLINE Assunto principal: Melanoma Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suíça